Net Margin - Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) - Alpha Spread

Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255

Watchlist Manager
Hebei Changshan Biochemical Pharmaceutical Co Ltd Logo
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Watchlist
Price: 10.31 CNY -1.34% Market Closed
Market Cap: 9.3B CNY
Have any thoughts about
Hebei Changshan Biochemical Pharmaceutical Co Ltd?
Write Note

Net Margin
Hebei Changshan Biochemical Pharmaceutical Co Ltd

-97.7%
Current
-22%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-97.7%
=
Net Income
-1.1B
/
Revenue
1.2B

Net Margin Across Competitors

Country CN
Market Cap 9.5B CNY
Net Margin
-98%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 860.1B USD
Net Margin
19%
Country DK
Market Cap 3.9T DKK
Net Margin
35%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country US
Market Cap 399.9B USD
Net Margin
44%
Country US
Market Cap 300.8B USD
Net Margin
22%
Country CH
Market Cap 214B CHF
Net Margin
20%
Country UK
Market Cap 243B USD
Net Margin
13%
Country CH
Market Cap 191.8B CHF
Net Margin
33%
Country US
Market Cap 168.6B USD
Net Margin
-5%

Profitability Report

View the profitability report to see the full profitability analysis for Hebei Changshan Biochemical Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-97.7%
=
Net Income
-1.1B
/
Revenue
1.2B
What is the Net Margin of Hebei Changshan Biochemical Pharmaceutical Co Ltd?

Based on Hebei Changshan Biochemical Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -97.7%.